New drug duo tested in fight against aggressive breast cancer
NCT ID NCT07359404
Summary
This study is testing whether combining two existing drugs, sacituzumab govitecan and bevacizumab, can help control advanced triple-negative breast cancer that has spread. It is for people whose cancer has worsened after at least one prior treatment. The main goals are to see if the combination can slow cancer growth and is safe for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Conditions
Explore the condition pages connected to this study.